Sample Content
Blog
Joomla! Default
Diseases/Conditions
Safety And Statistically Significant Improvement In Parkinson's Disease Shown By Gene Therapy Study | Safety And Statistically Significant Improvement In Parkinson's Disease Shown By Gene Therapy Study |
| www.medicalnewstoday.com/medicalnews.php?newsid=75016&nfid=crss | |
| Neurologix, Inc. (OTC Bulletin Board: NRGX) has announced in the journal The Lancet publication of positive results from the first ever gene therapy trial for Parkinson's disease and the first report of direct gene transfer into a patient's own brain cells for any adult neurodegenerative disease. [] |
| < Prev | Next > |
|---|
| Administrator |
| Submit Content |